CaV1.3 antagonist-1 是一种有效且高度选择性的 CaV1.3 L 型钙通道拮抗剂，IC50 为 1.7 μM。CaV1.3 antagonist-1 对 CaV1.3 LTCC 的抑制比 CaV1.2 LTCC 强 600 倍以上。CaV1.3 antagonist-1 是一种环戊基衍生物，具有用于帕金森病研究的潜力。
| Cas No. | 1391385-57-1 |
| 分子式 | C17H19ClN2O3 |
| 分子量 | 334.8 |
| 溶解度 | DMSO : 100 mg/mL (298.69 mM; Need ultrasonic) |
| 储存条件 | 4°C, protect from light |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | CaV1.3 antagonist-1 is a potent and highly selectiveCaV1.3 L-type calcium channel (LTCC)antagonist with anIC50of 1.7 μM. CaV1.3 antagonist-1 inhibits CaV1.3 LTCC >600-fold more potently than CaV1.2 LTCC. CaV1.3 antagonist-1, a cyclopentyl derivative, has the potential for Parkinson's disease research[1]. CaV1.3 antagonist-1 (Compound 8; 5 μM) exhibits 31.2% and 4.4% inhibition for CaV1.3 and CaV1.2 channel current in HEK293 cells, respectively. This correlates with the results of the FLIPR assay[1]. |
